Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-04-15 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: STRASBOURG (67000), Bas-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L'ANGLE : revenue, balance sheet and financial ratios
PHARMACIE DE L'ANGLE is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in STRASBOURG (67000),
this company of category PME
shows in 2023 a net income positive of 155 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'ANGLE (SIREN 503574535)
Indicator
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
155 390 €
258 347 €
406 290 €
156 400 €
113 700 €
133 310 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DE L'ANGLE generates positive net income of 155 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2023: 133 k€ -> 155 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
155 390 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 21%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
20.931%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.476%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE L'ANGLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
Debt ratio
9.312
0.961
0.261
24.017
21.79
20.931
Financial autonomy
71.589
76.296
73.214
61.382
64.923
57.476
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
20.932023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Good
In 2023, the debt ratio of PHARMACIE DE L'ANGLE (20.93) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
57.48%2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Good-10 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DE L'ANGLE (57.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 248.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
248.044
Liquidity indicators evolution PHARMACIE DE L'ANGLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
Liquidity ratio
248.487
243.594
240.171
333.135
378.422
248.044
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
248.042023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Good-7 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE L'ANGLE (248.04) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE L'ANGLE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE L'ANGLE is estimated at
1 833 520 €
(range 1 115 051€ - 2 577 518€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1115k€1833k€2577k€
1 833 520 €Range: 1 115 051€ - 2 577 518€
NAF 5 année 2023
Valuation method used
Net Income Multiple
155 390 €
×
11.8x
=1 833 521 €
Range: 1 115 052€ - 2 577 519€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'ANGLE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'ANGLE
What is the revenue of PHARMACIE DE L'ANGLE ?
The revenue of PHARMACIE DE L'ANGLE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE L'ANGLE profitable?
Yes, PHARMACIE DE L'ANGLE generated a net profit of 155 k€ in 2023.
Where is the headquarters of PHARMACIE DE L'ANGLE ?
The headquarters of PHARMACIE DE L'ANGLE is located in STRASBOURG (67000), in the department Bas-Rhin.
Where to find the tax return of PHARMACIE DE L'ANGLE ?
The tax return of PHARMACIE DE L'ANGLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'ANGLE operate?
PHARMACIE DE L'ANGLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart